GeneDx Holdings Corp. (WGS) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
GeneDx Holdings Corp. (WGS) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$74.63 MLiabilities$237.27 MNon-current liabilities$162.64 MEquity$244.22 MGross equity(calculated)$1.70 BCurrent assets$246.36 MAssets$481.49 MNon-current assets$235.13 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSAccounts receivableMarketable securitiesCash and cash equivalentsInventory, netPrepaid expenses and other current assetsIntangible assets, netProperty and equipment, netOperating lease right-of-use assetsOther assetsGoodwillAccounts payable and accrued expensesOther current liabilitiesShort-term lease liabilitiesLong-term debt, net of current portionLong-term lease liabilitiesDeferred taxesOther liabilitiesAdditional paid-in capitalAccumulated other comprehensive incomeClass A common stock, $0.0001 par value: 1,000,000,000 shares authorized, 29,803,164 and 29,245,296 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectivelyCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Accumulated deficitCurrent liabilitiesCurrent liabilities$74.63 MAccounts payable and accrued expensesAccounts payable and accrued expenses$42.09 MLiabilitiesLiabilities$237.27 MOther current liabilitiesOther current liabilities$26.83 MShort-term lease liabilitiesShort-term lease liabilities$5.71 MNon-current liabilitiesNon-current liabilities$162.64 MLong-term debt, net of current portionLong-term debt, net of current portion$96.84 MLong-term lease liabilitiesLong-term lease liabilities$64.86 MDeferred taxesDeferred taxes$873.00 KEquityEquity$244.22 MOther liabilitiesOther liabilities$71.00 KGross equity (calculated)Gross equity(calculated)$1.70 BCurrent assetsCurrent assets$246.36 MAccounts receivableAccounts receivable$83.61 MMarketable securitiesMarketable securities$72.23 MAssetsAssets$481.49 MCash and cash equivalentsCash and cash equivalents$60.32 MInventory, netInventory, net$17.82 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$12.38 MNon-current assetsNon-current assets$235.13 MIntangible assets, netIntangible assets, net$141.35 MProperty and equipment, netProperty and equipment, net$54.32 MAdditional paid-in capitalAdditional paid-in capital$1.70 BOperating lease right-of-use assetsOperating lease right-of-use assets$33.54 MOther assetsOther assets$4.28 MGoodwillGoodwill$1.64 MAccumulated other comprehensive incomeAccumulated other comprehensive income$342.00 KClass A common stock, $0.0001 par value: 1,000,000,000 shares authorized, 29,803,164 and 29,245,296 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectivelyClass A common stock$3.00 KAccumulated deficitAccumulated deficit−$1.45 B
Chart details

GeneDx Holdings Corp. (WGS) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
481,486,000 US dollars
Current assets
246,360,000 US dollars
Non-current assets
235,126,000 US dollars
Liabilities
237,265,000 US dollars
Current liabilities
74,628,000 US dollars
Non-current liabilities
162,637,000 US dollars
Equity
244,221,000 US dollars
Accounts receivable
83,610,000 US dollars
Marketable securities
72,231,000 US dollars
Cash and cash equivalents
60,317,000 US dollars
Inventory, net
17,820,000 US dollars
Prepaid expenses and other current assets
12,382,000 US dollars
Intangible assets, net
141,350,000 US dollars
Property and equipment, net
54,316,000 US dollars
Operating lease right-of-use assets
33,535,000 US dollars
Other assets
4,284,000 US dollars
Goodwill
1,641,000 US dollars
Accounts payable and accrued expenses
42,091,000 US dollars
Other current liabilities
26,828,000 US dollars
Short-term lease liabilities
5,709,000 US dollars
Long-term debt, net of current portion
96,836,000 US dollars
Long-term lease liabilities
64,857,000 US dollars
Deferred taxes
873,000 US dollars
Other liabilities
71,000 US dollars
Additional paid-in capital
1,698,427,000 US dollars
Accumulated other comprehensive income
342,000 US dollars
Class A common stock, $0.0001 par value: 1,000,000,000 shares authorized, 29,803,164 and 29,245,296 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
3,000 US dollars
Preferred Stock, $0.0001 par value: 1,000,000 shares authorized, 0 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
0 US dollars
Accumulated deficit
negative 1,454,551,000 US dollars
Gross equity (calculated)
1,698,772,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
GeneDx Holdings Corp. (WGS) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!